• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群与肝病的关系及其在膳食天然产物和益生菌的肝保护作用中的作用。

Gut Microbiota's Relationship with Liver Disease and Role in Hepatoprotection by Dietary Natural Products and Probiotics.

机构信息

Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangdong Engineering Technology Research Center of Nutrition Translation, Department of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China.

School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong 999077, China.

出版信息

Nutrients. 2018 Oct 8;10(10):1457. doi: 10.3390/nu10101457.

DOI:10.3390/nu10101457
PMID:30297615
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6213031/
Abstract

A variety of dietary natural products have shown hepatoprotective effects. Increasing evidence has also demonstrated that gut microorganisms play an important role in the hepatoprotection contributed by natural products. Gut dysbiosis could increase permeability of the gut barrier, resulting in translocated bacteria and leaked gut-derived products, which can reach the liver through the portal vein and might lead to increased oxidative stress and inflammation, thereby threatening liver health. Targeting gut microbiota modulation represents a promising strategy for hepatoprotection. Many natural products could protect the liver from various injuries or mitigate hepatic disorders by reverting gut dysbiosis, improving intestinal permeability, altering the primary bile acid, and inhibiting hepatic fatty acid accumulation. The mechanisms underlying their beneficial effects also include reducing oxidative stress, suppressing inflammation, attenuating fibrosis, and decreasing apoptosis. This review discusses the hepatoprotective effects of dietary natural products via modulating the gut microbiota, mainly focusing on the mechanisms of action.

摘要

多种膳食天然产物已显示出保肝作用。越来越多的证据表明,肠道微生物在天然产物发挥的保肝作用中起着重要作用。肠道菌群失调会增加肠道屏障的通透性,导致移位细菌和漏出的肠道来源产物通过门静脉到达肝脏,并可能导致氧化应激和炎症增加,从而威胁肝脏健康。靶向调节肠道微生物群代表了一种有前途的保肝策略。许多天然产物可以通过逆转肠道菌群失调、改善肠道通透性、改变初级胆汁酸和抑制肝脏脂肪酸积累来保护肝脏免受各种损伤或减轻肝障碍。其有益作用的机制还包括降低氧化应激、抑制炎症、减轻纤维化和减少细胞凋亡。本文主要讨论了通过调节肠道微生物群发挥保肝作用的膳食天然产物,重点讨论了其作用机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/6213031/39e8da44a4e8/nutrients-10-01457-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/6213031/bffa5729d596/nutrients-10-01457-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/6213031/39e8da44a4e8/nutrients-10-01457-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/6213031/bffa5729d596/nutrients-10-01457-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/6213031/39e8da44a4e8/nutrients-10-01457-g002.jpg

相似文献

1
Gut Microbiota's Relationship with Liver Disease and Role in Hepatoprotection by Dietary Natural Products and Probiotics.肠道微生物群与肝病的关系及其在膳食天然产物和益生菌的肝保护作用中的作用。
Nutrients. 2018 Oct 8;10(10):1457. doi: 10.3390/nu10101457.
2
Microbiota and Fatty Liver Disease-the Known, the Unknown, and the Future.肠道菌群与脂肪性肝病:已知、未知与未来。
Cell Host Microbe. 2020 Aug 12;28(2):233-244. doi: 10.1016/j.chom.2020.07.007.
3
Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.肠-肝轴与益生菌:它们在非酒精性脂肪性肝病中的作用
World J Gastroenterol. 2014 Nov 14;20(42):15518-31. doi: 10.3748/wjg.v20.i42.15518.
4
Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.肠道微生物群:非酒精性脂肪性肝病的新治疗靶点。
Expert Rev Gastroenterol Hepatol. 2019 Mar;13(3):193-204. doi: 10.1080/17474124.2019.1569513. Epub 2019 Jan 25.
5
Nonalcoholic Fatty Liver Disease and the Gut Microbiome.非酒精性脂肪性肝病与肠道微生物组。
Clin Liver Dis. 2016 May;20(2):263-75. doi: 10.1016/j.cld.2015.10.012. Epub 2015 Dec 24.
6
Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.综述文章:肠道微生物组作为慢性肝病发病机制和治疗的治疗靶点。
Aliment Pharmacol Ther. 2018 Jan;47(2):192-202. doi: 10.1111/apt.14397. Epub 2017 Oct 30.
7
Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches.肠道微生物群和氧化应激在非酒精性脂肪性肝病向肝癌进展中的作用:当前和创新的治疗方法。
Redox Biol. 2018 May;15:467-479. doi: 10.1016/j.redox.2018.01.009. Epub 2018 Feb 3.
8
Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?益生菌在非酒精性脂肪性肝病中的作用:肠道微生物组是否重要?
Nutrients. 2019 Nov 19;11(11):2837. doi: 10.3390/nu11112837.
9
Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota.通过调节肠道微生物群实现酒精性和非酒精性脂肪性肝病的精准医学
Am J Physiol Gastrointest Liver Physiol. 2016 Dec 1;311(6):G1018-G1036. doi: 10.1152/ajpgi.00245.2016. Epub 2016 Sep 29.
10
Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.肠-肝轴、肝硬化和门静脉高压:先有鸡还是先有蛋。
Hepatol Int. 2018 Feb;12(Suppl 1):24-33. doi: 10.1007/s12072-017-9798-x. Epub 2017 May 26.

引用本文的文献

1
Intestinal flora of hepatitis C after direct antiviral drug therapy: A review.直接抗病毒药物治疗后丙型肝炎的肠道菌群:综述
Medicine (Baltimore). 2025 Aug 1;104(31):e42301. doi: 10.1097/MD.0000000000042301.
2
In vitro antibacterial efficacy of a novel chicken-derived Bacillus subtilis GX15 strain and its protective mechanisms in mice challenged by Salmonella enterica serovar typhymurium.新型鸡源枯草芽孢杆菌GX15菌株的体外抗菌效果及其对鼠伤寒沙门氏菌攻击小鼠的保护机制
BMC Microbiol. 2025 Jul 2;25(1):380. doi: 10.1186/s12866-025-04107-z.
3
The Functional Components and Hepatic Protective Mechanism of Wolfberry Vinegar by Mixed-Culture Fermentation.

本文引用的文献

1
Natural Products for Prevention and Treatment of Chemical-Induced Liver Injuries.用于预防和治疗化学性肝损伤的天然产物
Compr Rev Food Sci Food Saf. 2018 Mar;17(2):472-495. doi: 10.1111/1541-4337.12335. Epub 2018 Feb 7.
2
Different Sex-Based Responses of Gut Microbiota During the Development of Hepatocellular Carcinoma in Liver-Specific -Knockout Mice.肝脏特异性敲除小鼠肝细胞癌发生过程中肠道微生物群基于性别的不同反应
Front Microbiol. 2018 May 16;9:1008. doi: 10.3389/fmicb.2018.01008. eCollection 2018.
3
Liver-Microbiome Axis in Health and Disease.
混合发酵枸杞醋的功能成分及肝脏保护机制
Foods. 2025 Apr 7;14(7):1278. doi: 10.3390/foods14071278.
4
Unlocking the power of probiotics, postbiotics: targeting apoptosis for the treatment and prevention of digestive diseases.释放益生菌、后生元的力量:针对细胞凋亡治疗和预防消化系统疾病。
Front Nutr. 2025 Mar 31;12:1570268. doi: 10.3389/fnut.2025.1570268. eCollection 2025.
5
alleviate Serovar Typhimurium-induced murine inflammatory/oxidative responses via the p62-Keap1-Nrf2 signaling pathway and cecal microbiota.通过p62-Keap1-Nrf2信号通路和盲肠微生物群减轻鼠伤寒血清型沙门氏菌诱导的小鼠炎症/氧化反应。
Front Microbiol. 2025 Jan 16;15:1483705. doi: 10.3389/fmicb.2024.1483705. eCollection 2024.
6
Mitigates Fructose-Induced Non-Alcoholic Fatty Liver in Rats.减轻果糖诱导的大鼠非酒精性脂肪肝。
Medicina (Kaunas). 2024 Oct 18;60(10):1713. doi: 10.3390/medicina60101713.
7
A Scoping Review on Hepatoprotective Mechanism of Herbal Preparations through Gut Microbiota Modulation.通过调节肠道菌群对草药制剂肝脏保护机制的范围综述
Curr Issues Mol Biol. 2024 Oct 16;46(10):11460-11502. doi: 10.3390/cimb46100682.
8
Therapeutic Role of Probiotics Against Environmental-Induced Hepatotoxicity: Mechanisms, Clinical Perspectives, Limitations, and Future.益生菌对环境诱导的肝毒性的治疗作用:机制、临床前景、局限性与未来展望
Probiotics Antimicrob Proteins. 2025 Apr;17(2):516-540. doi: 10.1007/s12602-024-10365-6. Epub 2024 Sep 24.
9
Effects of Several Tea-like Plants on Liver Injury Induced by Alcohol via Their Antioxidation, Anti-Inflammation, and Regulation of Gut Microbiota.几种茶样植物通过抗氧化、抗炎及调节肠道菌群对酒精所致肝损伤的影响
Foods. 2024 Aug 13;13(16):2521. doi: 10.3390/foods13162521.
10
Anti-inflammatory properties of polysaccharides from edible fungi on health-promotion: a review.食用菌多糖的抗炎特性对健康促进作用的综述
Front Pharmacol. 2024 Jul 26;15:1447677. doi: 10.3389/fphar.2024.1447677. eCollection 2024.
肝-微生物组轴在健康和疾病中的作用。
Trends Immunol. 2018 Sep;39(9):712-723. doi: 10.1016/j.it.2018.05.002. Epub 2018 May 26.
4
Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells.肠道微生物群介导的胆汁酸代谢通过 NKT 细胞调节肝癌。
Science. 2018 May 25;360(6391). doi: 10.1126/science.aan5931.
5
Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis.肝硬化患者的小肠转运与肠道微生物群改变
Front Physiol. 2018 May 1;9:470. doi: 10.3389/fphys.2018.00470. eCollection 2018.
6
Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages.肠道微生物衍生色氨酸代谢物可调节肝细胞和巨噬细胞的炎症反应。
Cell Rep. 2018 Apr 24;23(4):1099-1111. doi: 10.1016/j.celrep.2018.03.109.
7
Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease.肠道微生物群作为非酒精性脂肪性肝病炎症的驱动因素。
Mediators Inflamm. 2018 Jan 31;2018:9321643. doi: 10.1155/2018/9321643. eCollection 2018.
8
Gut microbiota in adolescents and the association with fatty liver: the EPOCH study.青少年肠道微生物群与脂肪肝的关系:EPOCH 研究。
Pediatr Res. 2018 Aug;84(2):219-227. doi: 10.1038/pr.2018.32. Epub 2018 Apr 18.
9
Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice.由肠道微生物群调节的胆汁酸代谢促进小鼠非酒精性脂肪性肝炎相关的肝细胞癌。
Oncotarget. 2018 Jan 6;9(11):9925-9939. doi: 10.18632/oncotarget.24066. eCollection 2018 Feb 9.
10
Apoptosis of enterocytes and nitration of junctional complex proteins promote alcohol-induced gut leakiness and liver injury.肠上皮细胞凋亡和连接复合体蛋白硝化促进酒精诱导的肠道通透性增加和肝损伤。
J Hepatol. 2018 Jul;69(1):142-153. doi: 10.1016/j.jhep.2018.02.005. Epub 2018 Feb 16.